Robert M. Day

31 papers receiving 2.0k citations

Robert M. Day's Hit Papers

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1) 2015 · 483 citations
4830+3+7Years since publication100200300400

Peers

Robert M. Day
Comparison fields: 5 of 101
  • Dermatology 865
  • Immunology 1.4k
  • Rheumatology 360
  • Pathology and Forensic Medicine 421
  • Ophthalmology 145
Replace Jennifer Clay Cather with:
Jennifer Clay Cather United States
Peter van de Kerkhof Netherlands
Caitriona Ryan United States
Sascha Gerdes Germany
Tiago Torres Portugal
Michel Le Maître France
Sergio Chimenti Italy
Charlotte Read United States
Leena Chularojanamontri Thailand
B K Bang South Korea
Robert M. Day relative to Jennifer Clay Cather United States Jennifer Clay Cather's profile →
Citations per field
00.5×5.4×
Jennifer Clay Cather · 1×
Citations per year

Countries citing papers authored by Robert M. Day

Since Specialization
Citations

This map shows the geographic impact of Robert M. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Day more than expected).

Fields of papers citing papers by Robert M. Day

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Day. The network helps show where Robert M. Day may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert M. Day, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert M. Day Line = papers co-authored together Robert M. Day links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
Hit paper breakdown →
2015483
2 2012217
3 2000176
4 2016144
5 2017126
6 2015125
7 1998100
8 196869
9 199167
10
Efficacy, tolerability, and pharmacodynamics of apremilast in recalcitrant plaque psoriasis: a phase II open-label study.
201365
11 201661
12 201360
13 201757
14 201651
15 196551
16 196251
17 199644
18 196034
19 198831
20
Three-fold reduction in the prevalence of tuberculosis over 25 years in Indonesia.
200730

About Robert M. Day

Robert M. Day is a scholar working on Immunology, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health, Physiology and Dermatology, having authored 32 papers that have together received 2.1k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (17 papers), Pharmaceutical studies and practices (7 papers), Asthma and respiratory diseases (6 papers), Ophthalmology and Eye Disorders (6 papers), Dermatology and Skin Diseases (5 papers), Glaucoma and retinal disorders (4 papers), Phosphodiesterase function and regulation (4 papers) and Mast cells and histamine (3 papers). The work is most often cited by research in Dermatology (865 citations), Immunology (1.4k citations), Rheumatology (360 citations), Pathology and Forensic Medicine (421 citations) and Ophthalmology (145 citations). Robert M. Day has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Kim Papp, Richard G. Langley, Kristian Reich, Joana Gonçalves, Randall M. Stevens, Craig L. Leonardi, ChiaChi Hu, Kenneth B. Gordon, Sergio Chimenti and Neil J. Korman. Their work appears in journals such as Journal of the American Academy of Dermatology, Annals of the Rheumatic Diseases, American Journal of Ophthalmology, Journal of Dermatological Science and Journal of the European Academy of Dermatology and Venereology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact